There is no official MOTS-c warning label
As of September 30, 2026, MOTS-c had no approved US label setting out who must avoid it.
That is a missing source of information, not permission for everyone to use it.
Pregnancy and breastfeeding remain gaps
As of September 30, 2026, the available research did not establish whether MOTS-c is safe during pregnancy or breastfeeding.
Make those topics part of the conversation if they apply to you. Ask how the gaps affect the decision for your situation.
Study entry rules are not medicine warnings
The registered MOTS-MET trial excludes people with diabetes and certain heart, kidney, liver and cancer conditions.
As of September 30, 2026, those were the researchers’ choices about who could join the study. They were not an official list of who must avoid the medicine.
Even if your condition is not on that study’s list, it does not mean the injection is safe for you.
Bring the whole picture to the visit
Have your medicine and supplement names ready. Include health conditions, recent changes and the main concern that brought you to care.
Ask which missing evidence matters for that concern and what other approaches the doctor can discuss.
Keep this in mind
As of September 30, 2026, there was no approved MOTS-c label to help decide whether it fits your health. Being allowed to join a study cannot answer that question either.
A question to take
How do my health history, medicines and pregnancy plans change the care discussion?
Open my notes